Cure My Disease

Don't miss your cure!

 Log in / Sign up

A new app maps kidney-friendly meals for dining out in singapore

NCT ID NCT07804316

Symptom relief Sponsor: Singapore Institute of Technology Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 04, 2026 · Last updated Sep 04, 2026

Summary

Researchers in Singapore are testing a mobile app that helps people with chronic kidney disease (CKD) choose suitable foods when dining out. The app, called RENDOFOMAP, lets users photograph their meals and provides guidance based on a map of kidney-friendly options. In this pilot study, 30 adults with CKD stages 3b to 5 will use the app for 12 days over 3 months. The goal is to see if the app improves their sense of empowerment, quality of life, and nutritional health.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A mobile application that maps kidney-friendly food choices when dining out in Singapore
What this could lead to
If it works, this app could help people with chronic kidney disease feel more in control of their diet and improve their quality of life when eating out.
What could go wrong
This is a small pilot study with only 30 participants, so results may not apply to everyone. The app's impact on health measures like blood tests may be limited over the short 3-month period.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participants will be recruited from inpatient and outpatient setting in a tertiary hospital

Ages

21 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Are fluent in English. This is necessary to ensure clear communication and understanding of study procedures and materials. * Adequate proficiency in using smartphone i.e. downloading app, taking photo, completing e-forms within the mobile applications. This is essential for participants to effectively use the mobile application being tested. * Diagnosed with CKD Stage 3B-5. This targets the specific patient population that the study aims to benefit. Exclusion Criteria: * Only fluent in languages other than English. This could hinder effective communication and understanding of the study. * Diagnosis of cognitive deficit or neurological disorder. These conditions could impair the ability to follow study procedures or provide reliable data. * Uncontrolled diabetes (HbA1c\>8.5%). This condition could introduce additional health risks and confound study results. * Recent hypoglycemic episodes. This could pose a safety risk during the study. * Newly initiated on dialysis or planning for dialysis within the next 6 months. These patients may have rapidly changing health conditions that could affect study outcomes. * Decompensated liver cirrhosis. This condition could complicate the interpretation of study results. * Pregnant and lactating. These conditions could introduce additional variables that affect study outcomes. * Inability to provide consent. This ensures that all participants can legally and ethically participate in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic kidney disease (stages 3B-5) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic kidney disease (stages 3B-5) CKD

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Singapore Institute of Technology

    RECRUITING

    Singapore, 828608, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.